Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02191488

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Quantification of ALA-induced PpIX Fluorescence During Brain Tumor Resection

Status
Active Not Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
540 (estimated)
Sponsor
David W. Roberts · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Removing a tumor from a patients brain is hard to do because, very often, brain tumors do not have boundaries that are easy for the patients surgeon to find. In many cases, the surgeon can't tell exactly where the tumor begins or ends. The surgeon usually can remove most of the patient's tumor by looking at the MRI images that were taken of the patient's brain before surgery. However, the surgeon does not have any good way to tell if the entire tumor has been removed or not. Removing the entire tumor is very important because leaving tumor behind may allow it to grow back which could decrease the chances of survival.

Conditions

Interventions

TypeNameDescription
DRUG5-aminolevulinic acid

Timeline

Start date
2014-07-01
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2014-07-16
Last updated
2025-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02191488. Inclusion in this directory is not an endorsement.

ALA-induced PpIX Fluorescence During Brain Tumor Resection (NCT02191488) · Clinical Trials Directory